Safety and Efficacy of ASN-002 Combined With a Hedgehog Pathway Inhibitor

Clinical trial NCT04416516 · COMPLETED

Trial details

NCT number: NCT04416516
Sponsor: Ascend Biopharmaceuticals Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Basal Cell Carcinoma Basal Cell Nevus Syndrome

Start date: 2020-07-16
Primary completion: 2024-02-14
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.